Matsoukas, Minos-Timotheos

< Back to all Authors
Group by: Item type | Date
Jump to:
Number of items: 4.


Ridgway, Harry, Orbell, John ORCID: 0000-0003-3485-5309, Matsoukas, Minos-Timotheos ORCID: 0000-0002-4642-8163, Kelaidonis, Konstantinos, Moore, Graham J, Tsiodras, Sotiris, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Chasapis, Christos T ORCID: 0000-0002-8728-6245, Gorgoulis, Vasilis G and Matsoukas, John ORCID: 0000-0001-5554-2964 (2023) W254 in furin functions as a molecular gate: elucidation of putative drug tunneling and docking by non-equilibrium molecular dynamics. Computational and Structural Biotechnology Journal. ISSN 2001-0370

Ridgway, Harry, Ntallis, Charalampos ORCID: 0000-0002-4189-5803, Chasapis, Christos T ORCID: 0000-0002-8728-6245, Kelaidonis, Konstantinos, Matsoukas, Minos-Timotheos ORCID: 0000-0002-4642-8163, Plotas, Panagiotis, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Moore, Graham, Tsiodras, Sotirios ORCID: 0000-0002-0463-4321, Paraskevis, Dimitrios ORCID: 0000-0001-6167-7152, Mavromoustakos, Thomas ORCID: 0000-0001-5309-992X and Matsoukas, John ORCID: 0000-0001-5554-2964 (2023) Molecular epidemiology of SARS-CoV-2: the dominant role of arginine in mutations and infectivity. Viruses, 15 (2). ISSN 1999-4915

Deraos, George, Kritsi, Eftichia, Matsoukas, Minos-Timotheos, Christopoulou, Konstantina, Kalbacher, Hubert, Zoumpoulakis, Panagiotis, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Matsoukas, John (2018) Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP82–98) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II. Brain Sciences, 8 (12). ISSN 2076-3425

Qaradakhi, Tawar, Matsoukas, Minos-Timotheos ORCID: 0000-0002-4642-8163, Hayes, Alan ORCID: 0000-0003-1398-3694, Rybalka, Emma ORCID: 0000-0002-4854-0036, Caprnda, Martin, Rimarova, Kvetoslava, Sepsi, Milan, Büsselberg, Dietrich, Kruzliak, Peter, Matsoukas, John ORCID: 0000-0001-5554-2964, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2017) Alamandine reverses hyperhomocysteinemia-induced vascular dysfunction via PKA-dependent mechanisms. Cardiovascular Therapeutics, 35 (6). ISSN 1755-5914